Top Industry Leaders in the AI Drug Discovery Market
Exscientia expands collaboration with Merck KGaA: This multi-year partnership leverages Exscientia's AI-powered drug design platform to discover small molecule drug candidates across several therapeutic areas like oncology, neuroinflammation, and immunology.
BenevolentAI partners with AstraZeneca: This collaboration utilizes BenevolentAI's AI platform to analyze vast datasets and identify promising drug targets for neurodegenerative diseases, aiming to accelerate preclinical research.
Intellia Therapeutics collaborates with Verily Life Sciences: This partnership combines Intellia's CRISPR gene editing technology with Verily's AI and data analytics expertise to optimize gene editing therapies for targeted diseases.
List ofย Artificial Intelligence in Drug Discoveryย Key companies in the market- IBM (US)
- Alphabet Inc (US)
- Atomwise Inc (US)
- Deep Genomics (Canada)
- Cloud Pharmaceuticals, Inc (US)
- Microsoft corporation (US)
- Insilico Medicine (China)
- Cyclica (Canada)
- BenevolentAI (UK)
- Exscientia (UK)